After Pfizer's News Of Promising Vaccine Results, Concerns Linger About Vaccine Equity for Under 12

After Pfizer's News Of Promising Vaccine Results, Concerns Linger About Vaccine Equity for Under 12 Year Olds




Source: PeopleImages / Getty


Pfizer announced a significant breakthrough on Monday regarding vaccinating elementary school-age children. New data from the vaccine trial for children under 12 showed the vaccine was safe for children 5-11 and had a similar immune system response as adults.  

As a part of the trial, children under 12 were given a modified dosage of the Pfizer COVID-19. ... Read more


via: https://kmojfm.com/wp/2021/09/after-pfizers-news-of-promising-vaccine-results-concerns-linger-about-vaccine-equity-for-under-12-year-olds/